Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Observational × Radiotherapy × Clear all

Status

Completed 43 Recruiting 38 Unknown 23 Active not recruiting 10 Withdrawn 4 Terminated 4 Not yet recruiting 3 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 3 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Specimen Handling 5 Surveys and Questionnaires 4 Observation 4 Drug Therapy 3 Chemoradiotherapy 3 Blood Specimen Collection 3 Surgical Procedures, Operative 2 Electrocardiography 2 Capecitabine 2 Biopsy 2 trifluridine tipiracil drug combination 1 tegafur-gimeracil-oteracil 1 somapacitan 1 olverembatinib 1 lorlatinib 1 lenvatinib 1 gallium 68 PSMA-11 1 brexucabtagene autoleucel 1 axicabtagene ciloleucel 1 Zoledronic Acid 1 Tegafur 1 Spermine Synthase 1 S 1 (combination) 1 Robotic Surgical Procedures 1 Rituximab 1 Radiotherapy 1 Radiography, Panoramic 1 Radiation 1 Protons 1 Proton Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06429995 2024-05-28

SFPMAMMA

University Medical Center Groningen

Enrolling by invitation

10,000 enrolled

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡